Dental implants fail from infection far more often than natural teeth do, and for decades no one could fully explain why standard antibiotics that work around real teeth so often fail around artificial ones. Researchers at Rutgers School of Dental Medicine now say they have found the mechanism: corroding titanium particles shed by the implant itself, not just the bacteria colonizing it.
Between 10% and 20% of dental implant patients eventually develop peri-implantitis, a serious infection that destroys the surrounding jawbone and resists treatment in more than half of cases, compared with natural-tooth gum disease, where antibiotics and cleaning typically resolve the problem. The study, published in PNAS Nexus, found that bacteria accumulating on implant surfaces create acidic biofilms that slowly corrode the titanium, releasing billions of microscopic metal particles into nearby tissue. Those particles coat themselves with a bacterial toxin and are then engulfed by macrophages, the immune cells responsible for clearing infection; because the cells cannot digest the metal, they become trapped in an overactive inflammatory state that progressively destroys bone rather than healing it.
Using human tissue samples, lab-cultured immune cells and genetically engineered mice, the researchers traced the effect to a specific calcium channel in macrophages called TRPC1. In mice bred without that channel, abscesses were dramatically smaller, inflammatory signaling dropped and bacterial clearance returned to normal. "For the first time, we show why all the antibiotic treatments that work around teeth do not work around implants," said Georgios Kotsakis, the study's senior author and assistant dean for clinical research at Rutgers. "Now that we know the cause, we can start developing therapeutics." Kotsakis's lab is already testing drug candidates that target the same pathway in human cells. The condition costs health systems worldwide more than $1 billion a year, and the discovery gives researchers, for the first time, a concrete drug target rather than another round of antibiotics aimed at bacteria that were never the whole story.